Celecoxib may be a viable treatment option for breast cancer patients not treated with chemotherapy

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 958308
Main Authors Harris, Randall E., Schwartzbaum, Judith A.
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 13.09.2022
Subjects
breast cancer
celecoxib
clinical trial
cyclooxygenase
inflammation
Oncology
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology
Edited by: Dayanidhi Raman, University of Toledo, United States
Reviewed by: O. Graciela Scharovsky, National University of Rosario, Argentina; Arun Chandrasekharan, Aster MIMS Hospital, India; Silvia Cecilia Pacheco Velázquez, Oregon Health and Science University, United States
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.958308